Literature DB >> 33527175

Risk of fractures in primary hyperparathyroidism: a systematic review and meta-analysis.

H Ejlsmark-Svensson1, L Rolighed2, T Harsløf3, L Rejnmark3,4.   

Abstract

An increased risk of fractures in primary hyperparathyroidism (PHPT) has been reported in a number of relatively small studies. Performing a systematic literature search, we identified available studies and calculated common estimates by pooling results from the individual studies in a meta-analysis. Searching EMBASE and PubMed, we identified published studies reporting the risk of fractures in PHPT compared to a control group. We calculated odds ratio (OR) with 95% confidence interval (CI). A total of 804 studies were identified of which 12 studies were included. Risk of any fracture was increased compared to controls (OR 2.01; 95% CI, 1.61-2.50; I2 46%, 5 studies). Analysis of fracture risk at specific sites showed an increased risk of fracture at the forearm (OR 2.36; 95% CI, 1.64-3.38; I2 0%, 4 studies) and spine (OR 3.00; 95% CI, 1.41, 6.37, I2 88%, 9 studies). Risk estimate for hip fractures was non-significantly increased (OR 1.27; 95% CI, 0.97-1.66; I2 0%, 3 studies). Risk of vertebral fractures (VFx) was also increased if analyses were restricted to only studies with a healthy control group (OR 5.76; 95% CI, 3.86-8.60; I2 29%, 6 studies), studies including patients with mild PHPT (OR 4.22; 95% CI, 2.20-8.12; I2 57%, 4 studies) or studies including postmenopausal women (OR 8.07; 95% CI, 4.79-13.59; I2 0%, 3 studies). PHPT is associated with an increased risk of fractures. Although a number of studies are limited-it seems that the risk is increased across different skeletal sites including patients with mild PHPT and postmenopausal women.

Entities:  

Keywords:  Fractures; Hypercalcemia; Meta-analysis; Primary hyperparathyroidism; Vertebral fractures

Mesh:

Year:  2021        PMID: 33527175     DOI: 10.1007/s00198-021-05822-9

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  23 in total

1.  Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism.

Authors:  Cristina Eller-Vainicher; Marcello Filopanti; Serena Palmieri; Fabio Massimo Ulivieri; Valentina Morelli; Volha V Zhukouskaya; Elisa Cairoli; Rosa Pino; Antonella Naccarato; Uberta Verga; Alfredo Scillitani; Paolo Beck-Peccoz; Iacopo Chiodini
Journal:  Eur J Endocrinol       Date:  2013-06-29       Impact factor: 6.664

2.  The risk of fractures in postmenopausal women with primary hyperparathyroidism.

Authors:  Simona De Geronimo; Elisabetta Romagnoli; Daniele Diacinti; Emilio D'Erasmo; Salvatore Minisola
Journal:  Eur J Endocrinol       Date:  2006-09       Impact factor: 6.664

3.  Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures.

Authors:  R J Wilson; S Rao; B Ellis; M Kleerekoper; A M Parfitt
Journal:  Ann Intern Med       Date:  1988-12-15       Impact factor: 25.391

4.  The threshold of bone mineral density for vertebral fractures in female patients with primary hyperparathyroidism.

Authors:  Hiroshi Kaji; Mika Yamauchi; Kazuo Chihara; Toshitsugu Sugimoto
Journal:  Eur J Endocrinol       Date:  2005-09       Impact factor: 6.664

5.  Incidence and prevalence of primary hyperparathyroidism in a racially mixed population.

Authors:  Michael W Yeh; Philip H G Ituarte; Hui Cynthia Zhou; Stacie Nishimoto; In-Lu Amy Liu; Avital Harari; Philip I Haigh; Annette L Adams
Journal:  J Clin Endocrinol Metab       Date:  2013-02-15       Impact factor: 5.958

Review 6.  Hyperparathyroidism.

Authors:  William D Fraser
Journal:  Lancet       Date:  2009-07-11       Impact factor: 79.321

7.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  BMJ       Date:  2009-07-21

8.  Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism.

Authors:  Edda Vignali; Giuseppe Viccica; Daniele Diacinti; Filomena Cetani; Luisella Cianferotti; Elena Ambrogini; Chiara Banti; Romano Del Fiacco; John P Bilezikian; Aldo Pinchera; Claudio Marcocci
Journal:  J Clin Endocrinol Metab       Date:  2009-04-28       Impact factor: 5.958

9.  Diagnosis and Management of Primary Hyperparathyroidism Across the Veterans Affairs Health Care System.

Authors:  Elizabeth A Alore; James W Suliburk; David J Ramsey; Nader N Massarweh; Courtney J Balentine; Hardeep Singh; Samir S Awad; Konstantinos I Makris
Journal:  JAMA Intern Med       Date:  2019-09-01       Impact factor: 21.873

10.  Undertreatment of primary hyperparathyroidism in a privately insured US population: Decreasing utilization of parathyroidectomy despite expanding surgical guidelines.

Authors:  Carolyn D Seib; Tong Meng; Insoo Suh; Robin M Cisco; Dana T Lin; Arden M Morris; Amber W Trickey; Electron Kebebew
Journal:  Surgery       Date:  2020-07-09       Impact factor: 3.982

View more
  4 in total

Review 1.  Secondary Osteoporosis and Metabolic Bone Diseases.

Authors:  Mahmoud M Sobh; Mohamed Abdalbary; Sherouk Elnagar; Eman Nagy; Nehal Elshabrawy; Mostafa Abdelsalam; Kamyar Asadipooya; Amr El-Husseini
Journal:  J Clin Med       Date:  2022-04-24       Impact factor: 4.964

2.  Analysis of Comorbidities, Clinical Outcomes, and Parathyroidectomy in Adults With Primary Hyperparathyroidism.

Authors:  Kristian F Axelsson; Märit Wallander; Helena Johansson; Nicholas C Harvey; Liesbeth Vandenput; Eugene McCloskey; Enwu Liu; John A Kanis; Henrik Litsne; Mattias Lorentzon
Journal:  JAMA Netw Open       Date:  2022-06-01

3.  Bone Turnover Markers in Response to Ultrasound-Guided Microwave Ablation for Primary Hyperparathyroidism.

Authors:  Wenjing Ni; Yue Yuan; Xiaoqiu Chu; Guofang Chen; Xue Han; Jie Li; Xinping Wu; Jianhua Wang; Chao Liu; Shuhang Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-01       Impact factor: 5.555

4.  Reduced fracture incidence in patients having surgery for primary hyperparathyroidism.

Authors:  Martin Nilsson; Elin Ståhl; Kristina E Åkesson; Mark Thier; Erik Nordenström; Martin Almquist; Anders Bergenfelz
Journal:  Clin Endocrinol (Oxf)       Date:  2022-03-04       Impact factor: 3.523

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.